Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity.

MLA

Reyes-Pérez, Itzel Viridiana, et al. “Cytokines (IL-15, IL-21, and IFN-γ) in Rheumatoid Arthritis: Association with Positivity to Autoantibodies (RF, Anti-CCP, Anti-MCV, and Anti-PADI4) and Clinical Activity.” Clinical Rheumatology, vol. 38, no. 11, Nov. 2019, pp. 3061–71. EBSCOhost, https://doi.org/10.1007/s10067-019-04681-4.

APA

Reyes-Pérez, I. V., Sánchez-Hernández, P. E., Muñoz-Valle, J. F., Martínez-Bonilla, G. E., García-Iglesias, T., González-Díaz, V., García-Arellano, S., Cerpa-Cruz, S., Polanco-Cruz, J., & Ramírez-Dueñas, M. G. (2019). Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity. Clinical Rheumatology, 38(11), 3061–3071. https://doi.org/10.1007/s10067-019-04681-4

Chicago

Reyes-Pérez, Itzel Viridiana, Pedro Ernesto Sánchez-Hernández, José Francisco Muñoz-Valle, Gloria Esther Martínez-Bonilla, Trinidad García-Iglesias, Verónica González-Díaz, Samuel García-Arellano, Sergio Cerpa-Cruz, Julissa Polanco-Cruz, and María Guadalupe Ramírez-Dueñas. 2019. “Cytokines (IL-15, IL-21, and IFN-γ) in Rheumatoid Arthritis: Association with Positivity to Autoantibodies (RF, Anti-CCP, Anti-MCV, and Anti-PADI4) and Clinical Activity.” Clinical Rheumatology 38 (11): 3061–71. doi:10.1007/s10067-019-04681-4.